Clinical

Dataset Information

A prospective observational study evaluating intestinal microbiome as a biomarker to predict the efficacy and toxicity of BRCA1/2 mutant metastatic castration resistant prostate cancer patietns receiveing PARP inhibitors


ABSTRACT: Interventions: case series:Nil Primary outcome(s): ORR;OS;PFS;AE Study Design: Sequential

DISEASE(S): Prostate Cancer

PROVIDER: 2695487 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR